← Leaderboards
Ayalew Mergia
University Of Florida
$4,480,743
Attributed
$4,480,743
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $354.6K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$4,480,743 · 3
By mechanism
R01$4,480,743 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Terence R. Flotte$26,412,339
- Janet K. Yamamoto$5,409,442
- Dongsheng Duan$17,353,422
- Arun Srivastava$10,395,461
- Mauricio De Aguiar Martins$18,939,893
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyDisease /Disorder ModelTechnology /Technique DevelopmentPolymerase Chain ReactionAids TherapyGene ExpressionVirus ReplicationHiv InfectionsGenomeCatsFeline Immunodeficiency VirusTissue /Cell CultureTransfection /Expression VectorScid MouseSimian Immunodeficiency VirusCellsAcquired Immunodeficiency SyndromeCd4 Positive T LymphocytesAnti-Retroviral AgentsGenerationsDevelopmental Therapeutics ProgramCombination Drug TherapyAnimal ModelBase
Grant awards (19)
Foamy Virus Vector for Immunodeficiency Viruses Therapy$316,928
R01 · FY2011 · AI · contact PI
Foamy Virus Vector for Immunodeficiency Viruses Therapy$320,129
R01 · FY2010 · AI · contact PI
Foamy Virus Vector for Immunodeficiency Viruses Therapy$323,362
R01 · FY2009 · AI · contact PI
Foamy Virus Vector for Immunodeficiency Viruses Therapy$323,362
R01 · FY2008 · AI · contact PI
Foamy Virus Vector for Immunodeficiency Viruses Therapy$354,625
R01 · FY2007 · AI · contact PI
Foamy Virus Vector for Immunodeficiency Viruses Therapy$213,121
R01 · FY2006 · AI · contact PI
Foamy Virus Vector for Immunodeficiency Viruses Therapy$218,250
R01 · FY2005 · AI
Functional Analysis of FIV ORF-A$254,552
R01 · FY2004 · AI
Foamy Virus Vector for Immunodeficiency Viruses Therapy$218,000
R01 · FY2004 · AI
Functional Analysis of FIV ORF-A$253,750
R01 · FY2003 · AI
Foamy Virus Vector for Immunodeficiency Viruses Therapy$108,750
R01 · FY2003 · AI
PROPHYLAXIS OF FETAL HEMATOPOIETIC CELLS FOR FIV$267,749
R01 · FY2002 · AI
Functional Analysis of FIV ORF-A$253,750
R01 · FY2002 · AI
FOAMY VIRUS VECTOR FOR IMMUNODEFICIENCY VIRUS THERAPY$203,926
R01 · FY2002 · AI
PROPHYLAXIS OF FETAL HEMATOPOIETIC CELLS FOR FIV$259,948
R01 · FY2001 · AI
FOAMY VIRUS VECTOR FOR IMMUNODEFICIENCY VIRUS THERAPY$162,284
R01 · FY2001 · AI
PROPHYLAXIS OF FETAL HEMATOPOIETIC CELLS FOR FIV$199,881
R01 · FY2000 · AI
FOAMY VIRUS VECTOR FOR IMMUNODEFICIENCY VIRUS THERAPY$177,154
R01 · FY2000 · AI
PROPHYLAXIS OF FETAL HEMATOPOIETIC CELLS FOR FIV$51,222
R01 · FY2000 · AI